Trial Profile
Open Label Extension Trial of Idebenone for Primary Progressive Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 May 2021
Price :
$35
*
At a glance
- Drugs Idebenone (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms IPPoMS-E
- 27 Apr 2021 Status changed from active, no longer recruiting to completed.
- 03 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 02 Oct 2015 Planned End Date changed from 1 Oct 2018 to 1 Aug 2019 as per ClinicalTrials.gov record.